Login:
 
Maini A, O’Brien A. Be vigilant for non-alcoholic fatty liver disease in primary care. Practitioner 2017;261(1806):19-22

Be vigilant for non-alcoholic fatty liver disease in primary care

28 Jul 2017Registered users

Non-alcoholic fatty liver disease (NAFLD) is now the most common cause of chronic liver disease in the Western world. Between 10 and 30% of NAFLD patients will develop non-alcoholic steatohepatitis (NASH) with a risk of progression to cirrhosis. Of those with NASH and fibrosis at presentation, studies have suggested that approximately 21% of patients will have some regression of fibrosis while 38% of patients will progress over five years’ follow-up.

Registered usersThis article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.